Generic Name: Cleobetasol propionate + Gentamicin sulphate
FDA Classification: Prescription
Generic Name: Cleobetasol propionate + Gentamicin sulphate
FDA Classification: Prescription
Cleobetasol propionate is indicated for short term treatment of severe resistant inflammatory skin disorders such as recalcitrant eczemas unresponsive to less potent corticosteroids and psoriasis. Gentamicin is used to treat severe systemic infections due to sensitive Gram-negative and other organisms. Gentamicin is also applied topically for localized infection. Short term use in the treatment of steroid responsive dermatoses resistant to other less potent topical corticosteroids such as: seborrheic dermatitis, atopic dermatitis, lichen simplex chronus, pruritus ani, psoriasis, later phase allergic contact dermatitis, later phase of irritant dermatitis, discoid lupus erythematosus,and lichen planus. Gentamicin is indicated for the treatment of susceptible organisms such as: Pseudomonas aeruginosa, Proteus, Escherichia coli, Klebsiella, Enterobacter and Serratia
Apply once or twice daily sparingly to the affected area until improvement occurs. Therapy should be discontinued when control is achieved. In the more responsive conditions this may be within a few days. If a longer course is necessary, it is recommended that treatment should not be continued for longer than 4 weeks without the patient’s condition being reviewed. Repeated short courses of Cleovate-G may be used to control exacerbations If continuous steroid treatment is necessary, a less potent preparation should be used. In very resistant lesions, especially where there is hyperkeratosis, the treatment area may be occluded for part of each 24 hours. Thereafter improvement can usually be maintained by application without occlusion
No reviews yet.
